The Patent Finder

Robarts Research Institute

Also on record
Records under this name other than the patents Robarts Research Institute holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 10 of 10 · Back to Robarts Research Institute

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,987,315Use of a Combination of Myxoma Virus and Rapamycin for Therapeutic Treatment
Formerly held
Term ended
Term ended Apr 19, 2026 · High confidence
Term endedTerm ended Apr 19, 2026High confidence
US 7,850,960Methods for Regulation of Stem Cells
Term ended
Term ended Jan 4, 2025 · High confidence
Term endedTerm ended Jan 4, 2025High confidence
US 8,372,397Methods for Regulation of Stem Cells
No holder on record
Term ended
Term ended Dec 30, 2024 · High confidence
Term endedTerm ended Dec 30, 2024High confidence
US 8,193,812Transceive Surface Coil Array for Magnetic Resonance Imaging and Spectroscopy
Held by another company
Lapsed on the fee record
Ended Jun 5, 2024 · Medium confidence
Lapsed on the fee recordEnded Jun 5, 2024Medium confidence
US 8,227,440Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection
Term ended
Term ended May 22, 2024 · USPTO record
Term endedTerm ended May 22, 2024USPTO record
US 7,799,324Using Undifferentiated Embryonic Stem Cells to Control the Immune System
Formerly held
Lapsed on the fee record
Ended Sep 21, 2022 · Medium confidence
Lapsed on the fee recordEnded Sep 21, 2022Medium confidence
US 8,791,084Inhibition of SOX9 function in the treatment of proteoglycan-associated pathophysiological conditions
Formerly held
Lapsed on the fee record
Ended Jul 29, 2022 · USPTO record
Lapsed on the fee recordEnded Jul 29, 2022USPTO record
US 7,582,614Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
Lapsed on the fee record
Ended Sep 1, 2021 · USPTO record
Lapsed on the fee recordEnded Sep 1, 2021USPTO record
US 8,512,713Myxoma Virus Mutants for Cancer Treatment
Formerly held
Lapsed on the fee record
Ended Aug 20, 2021 · High confidence
Lapsed on the fee recordEnded Aug 20, 2021High confidence
US 7,527,968Regeneration Initiating Cells
Lapsed on the fee record
Ended May 5, 2017 · High confidence
Lapsed on the fee recordEnded May 5, 2017High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited